electroCore, Inc. (ECOR)
NASDAQ: ECOR · IEX Real-Time Price · USD
5.76
+0.18 (3.23%)
Apr 26, 2024, 4:00 PM EDT - Market closed
electroCore Revenue
In the year 2023, electroCore had annual revenue of $16.03M with 86.57% growth. Revenue in the quarter ending December 31, 2023 was $5.19M with 102.77% year-over-year growth.
Revenue (ttm)
$16.03M
Revenue Growth
+86.57%
P/S Ratio
2.16
Revenue / Employee
$235,735
Employees
68
Market Cap
34.58M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 16.03M | 7.44M | 86.57% |
Dec 31, 2022 | 8.59M | 3.14M | 57.62% |
Dec 31, 2021 | 5.45M | 1.96M | 55.93% |
Dec 31, 2020 | 3.50M | 1.11M | 46.25% |
Dec 31, 2019 | 2.39M | 1.40M | 140.72% |
Dec 31, 2018 | 992.95K | 181.50K | 22.37% |
Dec 31, 2017 | 811.46K | 557.32K | 219.30% |
Dec 31, 2016 | 254.14K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Fortress Biotech | 84.51M |
Precision Optics Corporation | 19.22M |
Co-Diagnostics | 6.81M |
Evogene | 5.64M |
VYNE Therapeutics | 424.00K |
ECOR News
- 19 days ago - electroCore Announces the Launch of Truvaga Plus® for General Wellness - GlobeNewsWire
- 25 days ago - electroCore Expands Intellectual Property Portfolio - GlobeNewsWire
- 6 weeks ago - electroCore Announces Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire
- 6 weeks ago - electroCore to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 7 weeks ago - electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2023 Financial Results on Wednesday, March 13, 2024 - GlobeNewsWire
- 4 months ago - electroCore Expands Intellectual Property Portfolio for Nerve Stimulation Technology - GlobeNewsWire
- 5 months ago - Dr. Peter Staats to Host Analyst Day on the Science Behind gammaCore™ Non-Invasive Vagus Nerve Stimulation (nVNS) on Tuesday, November 21, 2023 - GlobeNewsWire
- 6 months ago - electroCore Announces Third Quarter 2023 Financial Results - GlobeNewsWire